₹ 1,605.80
-59.80 (-3.59%)
T
Tatva Chintan Pharma
₹ 1,605.80
Tatva Chintan Pharma Fundamentals
Company Valuation
Market Cap (₹ Cr.)
3,756
PE Ratio
62.00
PB Ratio
4.79
Dividend Yield
0.12%
ROE
5.38%
ROCE
7.57%
Book Value (₹)
348.26
Face Value (₹)
10.00
Analyse TATVA with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|
| Promoters | 72.02% | 72.02% | 72.02% | 72.02% | 72.02% |
| Domestic Institutional Investors (DII) | 3.86% | 3.33% | 2.99% | 3.11% | 3.21% |
| Foreign Institutional Investors (FII) | 3.39% | 4.17% | 3.82% | 3.93% | 4.38% |
| Public Investors | 18.29% | 17.91% | 18.32% | 17.48% | 17.08% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
TATVA Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Chemicals
Sub Sector
Chemicals & Petrochemicals
Company Classification
Microcap
BSE Scrip Code
543321
NSE Scrip Name
TATVA
ISIN
INE0GK401011

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






